Cancer Care

 

 
AAML08B1 Biology Study of Transient Myeloproliferative Disorder(TMD)in Children with Down Syndrome(DS)
Principal Investigator (?)
Study Number
AAML08B1
Summary
RATIONALE: Studying the genes expressed in samples of blood from patients with Down syndrome
may help doctors identify biomarkers related to cancer.

PURPOSE: This research study is looking at blood samples from newborns with Down syndrome.
Phase (?)
N/A
Sponsor (?)
Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

Contact Information

For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:

Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.